Class 1. Persistent Pulmonary Hypertension of the Newborn

Neurodevelopmental outcome in children between one and five years after persistent pulmonary hypertension of term and near-term newborns

Laetitia Atlan, Lionel Berthomieu, Caroline Karsenty, Géraldine Gascoin, Catherine Arnaud, Sophie BreinigUniversity Hospital and Toulouse III University.France Frontiers in PediatricsFront Pediatr 2024; 12: DOI: 10.3389/fped.2024.1450916 AbstractBackground: Persistent pulmonary hypertension of the newborn (PPHN) is a serious condition that affects 1-2 per 1,000 newborns. Scientific data report the existence of neurological developmental abnormalities between 10 and 30%, but […]

Neurodevelopmental outcome in children between one and five years after persistent pulmonary hypertension of term and near-term newborns Read More »

Oral sildenafil versus bosentan for treatment of persistent pulmonary hypertension of the newborn: a randomized controlled trial

Aditya Kallimath, Sujata Deshpande, Pari Singh, Reema Garegrat, Satyan Lakshminrusimha, Rajesh Maheshwari, Pradeep SuryawanshiBharati Vidyapeeth (Deemed to be University) Medical College. Imperial College. University of California Davis Children’s Hospital. Westmead Hospital.India, United Kingdom, United States and Australia BioMedical Central PediatricsBMC Pediatr 2024; 24: DOI: 10.1186/s12887-024-05107-0 AbstractBackground: Access to inhaled nitric oxide (iNO) is limited in low resource

Oral sildenafil versus bosentan for treatment of persistent pulmonary hypertension of the newborn: a randomized controlled trial Read More »

Current Pharmaceutical Strategies in the Management of Persistent Pulmonary Hypertension of the Newborn (PPHN): A Comprehensive Review of Therapeutic Agents

Divyanshi Kaplish, Jayant D. Vagha, Sachin Rathod, Aditya JainJawaharlal Nehru Medical College and Datta Meghe Institute of Higher Education and Research.India CureusCureus 2024; 16: DOI: 10.7759/cureus.70307 AbstractPersistent Pulmonary Hypertension of the Newborn (PPHN) is a life-threatening condition characterized by the failure of normal circulatory transition after birth, leading to sustained pulmonary hypertension and severe hypoxemia. Despite

Current Pharmaceutical Strategies in the Management of Persistent Pulmonary Hypertension of the Newborn (PPHN): A Comprehensive Review of Therapeutic Agents Read More »

Impact of Persistent Pulmonary Hypertension of the Newborn in Neonates with Dextro-transposition of the Great Arteries

Marco Modestini, Dario Massari, Susanne Huisman, Michel M.R.F. Struys, Marcus T.R. Roofthooft, Jaap Jan VosBeatrix Children’s Hospital, University Medical Center Groningen and University of Groningen.Netherlands Journal of Cardiothoracic and Vascular AnesthesiaJ Cardiothorac Vasc Anesth 2024; DOI: 10.1053/j.jvca.2024.09.141 AbstractObjectives: This study aimed to assess the impact of persistent pulmonary hypertension of the newborn (PPHN) on perioperative morbidity and

Impact of Persistent Pulmonary Hypertension of the Newborn in Neonates with Dextro-transposition of the Great Arteries Read More »

Extracorporeal Membrane Oxygenation with Bi-Caval Dual-Lumen Catheter in a Neonate with Persistent Pulmonary Hypertension and Interventricular Septal Hypertrophy

Sachin Dangi, Anup Thakur, Neelam Kler, Raja JoshiSir Ganga Ram Hospital.India Indian Journal of PediatricsInd J Pediatr 2024; DOI: 10.1007/s12098-024-05299-4 AbstractAbstract Not Available CategoryClass I. Persistent Pulmonary Hypertension of the NewbornSurgical and Catheter-mediated Interventions for Pulmonary Vascular Disease Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed Publication: Fresh (PHresh). Less than 1-2 years since publication

Extracorporeal Membrane Oxygenation with Bi-Caval Dual-Lumen Catheter in a Neonate with Persistent Pulmonary Hypertension and Interventricular Septal Hypertrophy Read More »

Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit

Kavita Patel, Sharon Thomson, Meera Vijayan, Marjorie Makoni, Peter N. Johnson, Katy Stephens, Stephen B. Neely, Jamie L. MillerUniversity Health, San Antonio. Oklahoma Children’s Hospital at Oklahoma University Health, University of Oklahoma College of Medicine and University of Oklahoma College of Pharmacy. Lucile Packard Children’s Hospital. United States Frontiers in PediatricsFront Pediatr 2024; 12DOI: 10.3389/fped.2024.1465785 AbstractObjectives: Vasopressin

Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit Read More »

Echocardiographic evaluation of myocardial dysfunction in term neonates with perinatal asphyxia

Javaria Rasheed, Muhammad Khalid, Iram Nawaz, Barera MaryamNishtar Medical University Hospital. Bakhtawar Amin Medical & Dental College. Pakistan Pakistan Journal of Medical SciencesPak J Med Sci 2024; 40: 2107-2111DOI: 10.12669/pjms.40.9.9501 AbstractBackground and Objective: One third of the neonatal deaths worldwide are attributed to perinatal asphyxia. We aimed to determine the prevalence and determinants of cardiac dysfunction, through

Echocardiographic evaluation of myocardial dysfunction in term neonates with perinatal asphyxia Read More »

Sildenafil as Bridge Therapy for Inhaled Nitric Oxide in Preterm Neonates

Harris Khawaja, Timothy A. Sanders, Michael Schreiber, Deborah Bondi, Pooja Shah, Gillian BrennanUniversity of Chicago Medicine and Comer Children’s Hospital.United States Journal of Pediatric Pharmacology and TherapeuticsJ Pediatr Pharmacol Ther 2024; 25: 525-529DOI: 10.5863/1551-6776-29.5.525 AbstractObjective: Inhaled nitric oxide (iNO) is a mainstay of treatment for infants with persistent pulmonary hypertension. However, abrupt discontinuation of inhaled nitric oxide

Sildenafil as Bridge Therapy for Inhaled Nitric Oxide in Preterm Neonates Read More »

Pharmacoepidemiology of combination pulmonary vasodilator therapy in critically ill infants

Karan R. Kumar, Elizabeth C. Ciociola, Kayla R. Skinner, Gargi M. Dixit, Sunshine Alvarez, Elijah K. Benjamin, Jeffrey C. Faulkner, Rachel G. Greenberg, Reese H. Clark, Daniel K. Benjamin Jr, Christoph P. Hornik, Jan Hau LeeDuke University School of Medicine. University of North Carolina School of Medicine. Pediatrix Center for Research. KK Women’s and Children’s

Pharmacoepidemiology of combination pulmonary vasodilator therapy in critically ill infants Read More »

Association of Right Ventricular Dysfunction with Risk of Neurodevelopmental Impairment in Infants with Pulmonary Hypertension

Rossana Romero Orozco, Tazuddin A. Mohammed, Kerri Carter, Shaaron Brown, Stephen Miller, Roy T. Sabo, Meredith Campbell Joseph, Uyen Truong, Megha Nair, Victoria Anderson, Jie Xu, Judith A. Voynow, Karen D. Hendricks-MuñozChildren’s Hospital of Richmond at VCU and Virginia Commonwealth University School of Medicine. UF Health Shands Children’s Hospital and University of Florida.  Children’s National

Association of Right Ventricular Dysfunction with Risk of Neurodevelopmental Impairment in Infants with Pulmonary Hypertension Read More »

Scroll to Top